CUAMC
China Universal Asset Management Company’s Monte Rosa Therapeutics GLUE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146K | Buy |
32,354
+20,031
| +163% | +$90.3K | 0.01% | 336 |
|
|
2025
Q1 | $57.2K | Sell |
12,323
-704
| -5% | -$3.27K | 0.01% | 409 |
|
|
2024
Q4 | $90.4K | Buy |
+13,027
| New | +$90.4K | 0.01% | 407 |
|
|
2023
Q4 | – | Sell |
-1,280
| Closed | -$6.13K | – | 450 |
|
|
2023
Q3 | $6.13K | Buy |
1,280
+633
| +98% | +$3.03K | ﹤0.01% | 379 |
|
|
2023
Q2 | $4.43K | Sell |
647
-9
| -1% | -$62 | ﹤0.01% | 382 |
|
|
2023
Q1 | $5.11K | Buy |
656
+164
| +33% | +$1.28K | ﹤0.01% | 364 |
|
|
2022
Q4 | $3.74K | Buy |
492
+55
| +13% | +$419 | ﹤0.01% | 331 |
|
|
2022
Q3 | $4K | Buy |
+437
| New | +$4K | ﹤0.01% | 298 |
|